Hereditary colorectal cancer: MYH-associated polyposis and other newly identified disorders

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 1, 2009, Pages 75-87

  Lindor, Noralane M ^a  

^a Mayo Clinic   (United States)

Author keywords

hereditary non polyposis colon cancer; mismatch repair; polyposis; serrated

Indexed keywords

APC PROTEIN; B RAF KINASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; DNA; DNA GLYCOSYLASE MUTY; K RAS PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; SMAD4 PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; COLON POLYPOSIS; COLON RESECTION; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEREDITY; HETEROZYGOSITY; HUMAN; MISMATCH REPAIR; PROCTOCOLECTOMY; RISK ASSESSMENT; TELANGIECTASIA;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA GLYCOSYLASES; DNA MISMATCH REPAIR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERPLASIA; INTESTINAL POLYPOSIS; PEDIGREE; PEUTZ-JEGHERS SYNDROME; PRECANCEROUS CONDITIONS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 60949112145     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2008.11.013     Document Type: Article

References (104)

1. Al-Tassan N., Chmiel N., Maynard J., et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 30 (2002) 227-232
2. Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 28 (2007) 258-275
3. Frosina G. Tumor suppression by DNA base excision repair. Mini Rev Med Chem 7 (2007) 727-743
4. Lu A., Li X., Gu Y., et al. Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys 35 (2001) 141-170
5. Cheadle J., and Sampson J. MUTYH-associated polyposis-From defect in base excision repair to clinical genetic testing. DNA Repair 6 (2007) 274-279
6. Sampson J., Dolwani S., Jones S., et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362 (2003) 39-41
7. Sieber O.M., Lipton L., Crabtree M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348 (2003) 791-799
8. Croitoru M., Cleary S., Di Nicola N., et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96 (2004) 1631-1634
9. Fleischmann C., Peto J., Cheadle J., et al. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer 109 (2004) 554-558
10. Lipton L., Halford S., Johnson V., et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63 (2003) 7595-7599
11. Nohmi T., Kim S.-R., and Yamada M. Modulation of oxidative mutagenesis and cancerogenesis by polymorphic forms of human DNA repair enzymes. Mutation Res 591 (2005)
12. van Puijenbroek M., Nielsen M., Tops C., et al. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G>T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res 14 (2008) 139-142
13. Halford S., Rowan A., Lipton L., et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 162 (2003) 1545-1548
14. Isidro G., Laranjeira F., Pires A., et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat 24 (2004) 353-534
15. Wang L., Baudhuin L., Boardman L., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127 (2004) 9-16
16. Nielsen M., Franken P., Reinards T., et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 42 (2005) e54
17. Croitoru M., Cleary S., Berk T., et al. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients. J Surg Oncol 95 (2007) 499-506
18. Gismondi V., Meta M., Bonelli L., et al. Prevalence of the Y165C, G382D, and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 109 (2004) 680-684
19. Aretz S., Uhlhaas S., Goergens H., et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119 (2006) 807-814
20. Jenkins M., Croitoru M., Monga N., et al. Risk of colorectal cancer in monoallelic and biallelic carriers of myh mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 15 (2006) 312-314
21. Nielsen M., Poley J., Verhoef S., et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol 59 (2006) 1212-1215
22. Nielsen M., Hes F., Nagengast F., et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71 (2007) 427-433
23. Jo W., Bandipalliam P., Shannon K.M., et al. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol 3 (2005) 1022-1028
24. Ponti G., Ponz de Leon M., Maffei S., et al. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 68 (2005) 442-447
25. Ponti G., Venesio T., Losi L., et al. BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. J Invest Dermatol 127 (2007) 1387-1391
26. Baglioni S., and Genuardi M. Simple and complex genetics of colorectal cancer susceptibility. Am J Med Genet C Semin Med Genet 129 (2004) 35-43
27. Lejeune S., Guillemot F., Triboulet J., et al. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat 27 (2006) 1064
28. Lipton L., and Tomlinson I. The genetics of FAP and FAP-like syndromes. Fam Cancer 5 (2006) 221-226
29. Farrington S., Tenesa A., Barneston R., et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 77 (2005) 112-119
30. Webb E., Rudd M., and Houlston R. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet 79 (2006) 768-774
31. Balaguer F., Castellvi-Bel S., Castells A., et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 5 (2007) 379-387
32. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Colorectal Cancer Screening 1 (2008)
33. Vogelstein B., Fearon E., Hamilton S., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
34. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
35. La A., Peltomaki P., Leach F.S., et al. Clues to the pathogenesis of familial colorectal cancer. Science 260 (1993) 812-816
36. Ionov Y., Peinado M.A., Malkhosyan S., et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993 Jun 10) 558-561
37. Iino H., Jass J., Simms L., et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?. J Clin Pathol 52 (1999) 5-9
38. Biemer-Huttmann A., Walsh M., McGuckin M., et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 6 (2000) 1909-1916
39. Smith G., Carey F., Beattie J., et al. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 99 (2002) 9433-9438
40. Goldstein N., Bhanot P., Odish E., and Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119 (2003) 778-796
41. Hawkins N., and Ward R. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93 (2001) 1307-1313
42. Ogino S., Cantor M., Kawasaki T., et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterized by quantitative DNA methylation analysis and prospective cohort studies. Gut 55 (2006) 1000-1006
43. Song G., Deng G., Bell I., et al. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Int J Oncol 26 (2005) 745-750
44. Tanaka H., Deng G., Matsuzaki K., et al. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int J Cancer 118 (2005) 2765-2771
45. van Rijnsoever M., Grieu F., Elsaleh H., et al. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51 (2002) 797-802
46. Toyota M., Ohe-Toyota M., Ahuja N., and Issa J. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci USA 97 (2000) 710-715
47. Kambara T., Simms L., Whitehall V., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
48. Yang S., Farraye F., Mack C., et al. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28 (2004) 1452-1459
49. Jass J. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2 (2005) 398-405
50. Sumner H., Wasserman N., and McClain C. Giant hyperplastic polyposis of the colon. Dig Dis Sci 26 (1981) 85-89
51. Jeevaratnam P., Cottier D.S., Browett J., et al. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 179 (1996) 20-25
52. Jass J. Origins of familial cancer: histopathological persepctives. J Clin Pathol 50 (1997) 892-895
53. Rashid A., Houlihan P., Booker S., et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119 (2000) 323-332
54. Hyman N., Anderson P., and Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 47 (2004) 2101-2104
55. ARF but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet 10 (2001) 55-62
56. Keljo D., Weinberg A., Winick N., and Tomlinson G. Rectal cancer in an 11-year-old girl with hyperplastic polyposis. J Pediatr Gastroenterol Nutr 28 (1999) 327-332
57. Lage P., Cravo M., Sousa R., et al. Management of portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 99 (2004) 1779-1784
58. Beach R., Chan A., Wu T., et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 166 (2005) 1069-1075
59. Chan A., Issa J., Morris J., et al. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160 (2002) 529-536
60. Young J., Barker M., Simms L., et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 3 (2005) 254-263
61. Vasen H., Mecklin J., Khan P., and Lynch H. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 334 (1991) 424-425
62. Higuchi T., and Jass J. Serrated polyps of the colorectum. J Clin Pathol 57 (2004) 675-681
63. Aaltonen L., Jass J., and Howe J. Juvenile polyposis. In: Hamilton S., and Aaltonen L. (Eds). Pathology & genetics. Tumours of the digestive system (2000), IARC Press, Lyon 130-132
64. Jass J., Williams C., Bussey H., and Morson B. Juvenile polyposis-a precancerous condition. Histopathology 13 (1988) 619-630
65. Coburn M., Pricolo V., DeLuca F., and Bland K. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 2 (1995) 386-391
66. Brosens L., van Hattem W., Jansen M., et al. Gastrointestinal polyposis syndromes. Curr Mol Med 7 (2007) 29-46
67. Howe J., Mitros F., and Summers R. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 5 (1998) 751-756
68. Jarvinen H., and Franssila K. Familial juvenile polyposis coli; increased risk of colorectal cancer. Gut 25 (1984) 792-800
69. Heldin C., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
70. Kim B., Li C., Qiao W., et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441 (2006) 1015-1019
71. Bevan S., Woodford-Richens K., Rozen P., et al. Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut 45 (1999) 406-408
72. Howe J., Sayed M., Ahmed A., et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 41 (2004) 484-491
73. Roth S., Sistonen P., Salovaara R., et al. SMAD genes in juvenile polyposis. Genes Chromosomes Cancer 26 (1999) 54-61
74. Sweet K., Willis J., Zhou X., et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294 (2005) 2465-2473
75. Burger B., Uhlhaas S., Mangold E., et al. Novel de novo mutation of MADH4/SMAD4 in a patient with juvenile polyposis. Am J Med Genet 110 (2002) 289-291
76. Gallione C., Repetto G., Legius E., et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363 (2004) 852-859
77. Gallione C., Richards J., Letteboer T., et al. SMAD4 mutations found in unselected HHT patients. J Med Genet 43 (2006) 793-797
78. Bisgaard M., Jager A., Myrhoj T., et al. Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation. Hum Mutat 20 (2002) 20-27
79. Wijnen J., Vasen H., Kahn M., et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339 (1998) 511-518
80. Burke W., Petersen G., Lynch P., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 277 (1997) 915-919
81. Lindor N., Rabe K., Petersen G., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 293 (1979-85)
82. Jass J. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 12 (2006) 4943-4950
83. Llor X., Pons E., Xicola R., et al. Differential features of colorectal cancers fulfilling Amsterdam Criteria without involvement of the mutation pathway. Clin Cancer Res 11 (2005) 7304-7310
84. Dove-Edwin I., De Jong A., Adams J., et al. Propsective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology 2006 130 (1995-2000)
85. Mueller-Koch Y., Vogelsang H., Kopp R., et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 54 (2005) 1733-1740
86. Valle L., Perea J., Carbonell P., et al. Clinicopathologic and pedigree differences in Amsterdam-I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25 (2007) 781-786
87. Hendriks Y., deJong A., Morreaqu H., et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 56 (2006) 213-225
88. Iyer R., Pluciennik A., Burdett V., and Modrich P. DNA mismatch repair: functions and mechanisms. Chem Rev 106 (2006) 302-323
89. Chao E., and Lipkin S. Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res 34 (2006) 840-852
90. Vasen H., Moslein G., Alonso A., et al. Guidelines for the clinical management of Lynch syndrome. J Med Genet 44 (2007) 353-362
91. Lucci-Cordisco E., Zito I., Gensini F., and Genuardi M. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A 122 (2003) 325-334
92. Hampel H., and Peltomaki P. Hereditary colorectal cancer: risk assessment and management. Clin Genet 58 (2000) 89-97
93. Hamilton S., Liu B., Parsons R., et al. The molecular basis of Turcot's syndrome. N Engl J Med 332 (1995) 839-847
94. Felton K., Gilchrist D., and Andrew S. Constitutive deficiency in DNA mismatch repair. Clin Genet 71 (2007) 483-498
95. Gutmann D., Aylsworth A., Carey J., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278 (1997) 51-57
96. Wang Q., Montmain G., Ruano E., et al. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 112 (2003) 117-123
97. Menko F., Kaspers G., Meijer G., et al. A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer 3 (2004) 123-127
98. Ostergaard J., Sunde L., and Okkels H. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6. Am J Med Genet A 139 (2005) 96-105
99. Trimbath J., Petersen G., Erdman S., et al. Cafe-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?. Fam Cancer 1 (2001) 101-105
100. Pedroni M., Tamassia M., Percesepe A., et al. Microsatellite instability in multiple colorectal tumors. Int J Cancer 81 (1999) 1-5
101. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
102. Young J., and Jass J. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15 (2006) 1778-1784
103. Young J., Jenkins M., Parry S., et al. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 56 (2007) 1453-1459
104. Burt R., and Jass J. Hyperplastic polyposis. In: Hamilton S., and Aaltonen L. (Eds). World Health Organisation classification of tumours. Pathology & genetics. Tumours of the digestive system (2000), IARC Press, Lyon